Fundraising Fox

Aravive

Houston, US · Texas corporation · 2 known investors

Biotech

Founders & leadership

AG
Amato GiacciaFounder
RH
Rudy HowardChief Financial Officer
RB
Robert B. GellerChief Medical Officer
GM
Gail McIntyreChief Executive Officer
LS
Leonard Scott DoveChief Operating Officer
JB
Joshua BrummExecutive
JS
Jay ShepardExecutive
JC
Jeffrey ClelandExecutive
PW
Paul WestbergExecutive
SC
Sigurd C. KirkNamed on SEC filing
MW
Michael W. RogersNamed on SEC filing
PT
Peter T.C. HoNamed on SEC filing

Investors · 2

3E Bioventures CapitalPalo Alto
Advent Life SciencesLondon

Reported raises · per SEC filings

Form D private placements

$106.6M disclosed across 3 rounds · 2014–2022

▶$41.6MraisedOct 2022 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rudy HowardExecutive Officer
  • Fredric N. EshelmanExecutive Officer, Director
  • Sigurd C. KirkDirector
  • Michael W. RogersDirector
  • Peter T.C. HoDirector
  • Robert B. GellerExecutive Officer
  • Gail McIntyreExecutive Officer, Director
  • Leonard Scott DoveExecutive Officer
  • Eric ZhangDirector
  • Amato GiacciaDirector
  • John A. HohneckerDirector
Offering amount
$41.6M
Amount sold
$41.6M
Sales commissions
$1.1M
Placement agents
MTS Securities, LLC
First sale
Oct 2022
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55MraisedFeb 2014 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael DybbsDirector
  • Shahzad MalikDirector
  • Srinivas AkkarajuDirector
  • Jeffrey ClelandExecutive Officer, Director
  • Anthony SunDirector
  • Francesco De RubertisDirector
  • Joshua BrummExecutive Officer
  • Edmon JenningsDirector
  • Jay ShepardDirector
  • Paul WestbergExecutive Officer
Offering amount
$55M
Amount sold
$55M
First sale
Feb 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedFeb 2014 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony SunDirector
  • Joshua BrummExecutive Officer
  • Jay ShepardDirector
  • Shahzad MalikDirector
  • Edmon JenningsDirector
  • Francesco De RubertisDirector
  • Srinivas AkkarajuDirector
  • Jeffrey ClelandExecutive Officer, Director
  • Paul WestbergExecutive Officer
  • Michael DybbsDirector
Offering amount
$10M
Amount sold
$10M
First sale
Feb 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Aravive?
Aravive was founded by Amato Giaccia.
Who are Aravive's investors?
Aravive's investors include 3E Bioventures Capital, Advent Life Sciences.
How much funding has Aravive raised?
Aravive has disclosed $106.6M raised across 3 rounds.
Where is Aravive headquartered?
Aravive is headquartered in Houston, US.